Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
SSY Group Limited (HK:2005)
:2005
Holding HK:2005?
Track your performance easily
2005 Stock Chart & Stats
Day’s Range― - ―
52-Week RangeHK$3.11 - HK$5.20
Previous CloseN/A
Volume3.59M
Average Volume (3M)3.02M
Market Cap
$9.26B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)6.8
Beta0.65
Next Earnings
Apr 01, 2025EPS EstimateN/A
Last Dividend Ex-Date
Sep 12, 2024Dividend Yield5.7%
Share Statistics
EPS (TTM)0.46
Shares Outstanding2,957,959,500
10 Day Avg. Volume3,388,403
30 Day Avg. Volume3,020,879
Standard Deviation0.11
R-Squared0.14
Alpha0.00118
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)2.45
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
HK$5.22Price Target Upside65.22% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
SSY Group News
PremiumCompany Announcements
SSY Group Gains Approval for Key Drug Developments
PremiumCompany Announcements
SSY Group Secures Approval for Vonoprazan Fumarate Tablets
PremiumCompany Announcements
SSY Group’s Benidipine Hydrochloride Receives Approval for Market Release
PremiumCompany Announcements
SSY Group Gains Approval for Key Medical Product
PremiumCompany Announcements
SSY Group Gains Approval for Nikethamide DrugPremiumCompany Announcements
SSY Group Gains Key Approval for Paracetamol Tablets
PremiumCompany Announcements
SSY Group Gains Approval for Furosemide InjectionPremiumCompany Announcements
SSY Group Renews Key Agreements with Sichuan KelunOptions Prices
Currently, No data available
---
Ownership Overview
―
Insiders
2.01% Mutual Funds
― Other Institutional Investors
95.93% Public Companies and
Individual Investors
2005 FAQ
What was SSY Group Limited’s price range in the past 12 months?
SSY Group Limited lowest stock price was HK$3.11 and its highest was HK$5.20 in the past 12 months.
What is SSY Group Limited’s market cap?
SSY Group Limited’s market cap is $9.26B.
When is SSY Group Limited’s upcoming earnings report date?
SSY Group Limited’s upcoming earnings report date is Apr 01, 2025 which is in 59 days.
How were SSY Group Limited’s earnings last quarter?
Currently, no data Available
Is SSY Group Limited overvalued?
According to Wall Street analysts SSY Group Limited’s price is currently Undervalued.
Does SSY Group Limited pay dividends?
SSY Group Limited pays a Annually dividend of HK$0.079 which represents an annual dividend yield of 5.7%. See more information on SSY Group Limited dividends here
What is SSY Group Limited’s EPS estimate?
SSY Group Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does SSY Group Limited have?
SSY Group Limited has 2,957,959,500 shares outstanding.
What happened to SSY Group Limited’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of SSY Group Limited?
Currently, no hedge funds are holding shares in HK:2005
---
SSY Group Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
HK$5.22 (65.22% Upside)
HK$5.22 (65.22% Upside)
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-29.57%
12-Months-Change
Fundamentals
Return on Equity
20.08%
Trailing 12-Months
Asset Growth
11.15%
Trailing 12-Months
Company Description
SSY Group Limited
SSY Group Ltd is a specialty and generic drug manufacturing company. The company reports multiple segments including pharmaceutical products, medical materials, services income, and rental income. The company derives a vast majority of its revenue principally from the sale of finished medicines to hospitals and distributors. Revenue generation is driven mostly by its sales of pharmaceutical products, followed by medical materials. Over 95% of SSY Group's revenue and operating profits are derived from China.
---
2005 Stock 12 Month Forecast
Average Price Target
HK$5.22
▲(65.22% Upside)
Technical Analysis
Sino Biopharmaceutical
―
CSPC Pharmaceutical Group
―
China Medical System Holdings
―
Comba Telecom Systems Holdings
―
Livzon Pharmaceutical Group
―
Best Analysts Covering 2005
1 Year
1 Year Success Rate
0/1 ratings generated profit
1 Year Average Return
-10.20%
reiterated a buy rating last month
Copying Jacqueline Wen Dai's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -10.20% per trade.
---